Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
This Week in The Journal

This Week in The Journal

Teresa Esch [Ph.D.]
Journal of Neuroscience 1 December 2021, 41 (48) 9859; DOI: https://doi.org/10.1523/JNEUROSCI.twij.41.48.2021
Teresa Esch
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Type II Taste Cells Activate Type I Taste Cells

Yuryanni A. Rodriguez, Jennifer K. Roebber, Gennady Dvoryanchikov, Vivien Makhoul, Stephen D. Roper, et al.

(see pages 9860–9871)

Taste buds contain three types of taste cells. Type III cells express proton-selective ion channels that sense sour tastes. Type II cells express G-protein-coupled receptors that sense sweet, bitter, and/or umami tastes. And Type I cells, the most numerous taste-cell type, are thought to have glia-like functions, ensheathing other taste cells, limiting the spread of neurotransmitters, and regulating ionic balance in the taste bud. Type I cells may also contribute to the perception of sodium, however (Baumer-Harrison et al., 2020, J Neurosci 40:7795), and Rodriguez et al. show that Type I cells respond to ATP, the neurotransmitter released by Type II cells, which may allow them to modulate perception of other tastes as well.

Type I cells strongly express the GABA-synthesizing enzyme Gad2. Therefore, the authors used the Gad2 promoter to drive expression of a fluorescent calcium sensor predominantly in Type I cells. Treating dissociated taste bud cells with ATP increased intracellular calcium levels in 50–75% of Type I cells by stimulating release from intracellular stores. In contrast, treating cells with 5-HT, the neurotransmitter released by Type III cells, had no effect. ATP also increased calcium levels in Type I cells in intact taste buds in lingual slices. More importantly, whereas dissociated taste cells did not respond to bitter tastants, those in taste buds did. These responses were significantly reduced by pretreating slices with an ATPase, an ATP analog that desensitizes ATP-sensitive purinoceptors, or purinoceptor antagonists. Similarly, blocking ATP release from Type II cells reduced Type I cell responses to tastants.

These data suggest that ATP released by Type II taste cells in response to bitter tastants activates purinoceptors on Type I cells, leading to calcium release from intracellular stores. The effect of this calcium elevation is unclear, but one possibility is that it triggers the release of GABA, which is synthesized in Type I cells. Future work should determine whether sweet and umami tastants also lead to indirect stimulation of calcium elevation in Type I cells and investigate how such responses affect taste perception.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

The Gad2 promoter drives expression of GFP (green) in Type I taste cells (cyan, top) but not in Type II cells (red, bottom). See Rodriguez et al. for details.

Hyperactivation of ErbB Signaling Kills Oligodendrocytes

Xu Hu, Guanxiu Xiao, Li He, Xiaojie Niu, Huashun Li, et al.

(see pages 9872–9890)

Multiple lines of evidence suggest that improper myelination contributes to the pathophysiology of schizophrenia. First, symptoms of schizophrenia typically emerge late in adolescence, when myelination of fiber tracts connecting frontal and temporal lobes is underway. Second, the integrity of white matter tracts is lower than normal starting at the time of symptom onset in people with schizophrenia. Third, the number of oligodendrocytes—the glial cells that produce myelin in the CNS—is significantly lower in people with schizophrenia than in controls. Finally, several candidate risk genes for schizophrenia, including those encoding neuregulin and its ErbB receptors, regulate oligodendrocyte proliferation and gene expression (Bennett, 2011, Prog Neurobiol 95:275). Adding to this, Hu, Xiao, He, et al. show that excessive activation of ErbB signaling disrupts myelination in mice.

The authors increased activation of ErbB3, ErbB4, and downstream effectors in oligodendrocytes of adolescent mice by inducing expression of a mutant form of ErbB2, which dimerizes with ErbB3 and ErbB4. Hyperactivation of ErbB signaling led to deficient myelination and consequently to ataxia. Notably, however, different cellular and molecular mechanisms produced these outcomes when ErbB signaling was increased at different stages of oligodendrocyte differentiation. Activating ErbB signaling predominantly in oligodendrocyte precursor cells (OPCs) led to apoptosis of these cells. This resulted in reduced numbers of postmitotic oligodendrocytes and hypomyelination of white matter tracts. There was no sign of myelin fragmentation or degeneration, and no gliosis in white matter tracts in these mice, however. In contrast, activating ErbB signaling predominantly in mature (my elinating) oligodendrocytes led to pronounced gliosis, suggestive of an inflammatory response, and to the death of mature oligodendrocytes by programmed necrosis. This resulted in the fragmentation of myelin sheaths and an increase in the number of OPCs—consistent with previous work showing that demyelination triggers OPC proliferation. Importantly, regardless of where ErbB signaling was induced, ceasing transgene expression after 6 d led to a reversal of pathology; if transgene expression was continued for just a few more days, however, pathology continued to progress after expression was suppressed.

These results indicate that excessive signaling mediated by ErbB disrupts myelination by inducing apoptosis in OPCs and inducing necroptosis in mature oligodendrocytes. If this occurs in people with schizophrenia, it may disrupt communication between frontal and temporal lobes and thus contribute to multiple symptoms. Early intervention may be able to restore normal function, however.

Footnotes

  • This Week in The Journal was written by Teresa Esch, Ph.D.

Back to top

In this issue

The Journal of Neuroscience: 41 (48)
Journal of Neuroscience
Vol. 41, Issue 48
1 Dec 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
This Week in The Journal
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
This Week in The Journal
Journal of Neuroscience 1 December 2021, 41 (48) 9859; DOI: 10.1523/JNEUROSCI.twij.41.48.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
This Week in The Journal
Journal of Neuroscience 1 December 2021, 41 (48) 9859; DOI: 10.1523/JNEUROSCI.twij.41.48.2021
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Type II Taste Cells Activate Type I Taste Cells
    • Hyperactivation of ErbB Signaling Kills Oligodendrocytes
    • Footnotes
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • This Week in The Journal
  • This Week in The Journal
  • This Week in The Journal
Show more This Week in The Journal
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.